Skip to content

PRO 425942SRecalls & reported problems

Stryker GmbH · Suprapectineal Flex Plate 12-hole, left · Class 2 · Implant

All models of PRO (10)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07613327546606), received between May 15, 2025 and May 15, 2025 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 1 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Arthritis1
  • Bone Fracture(s)1
  • Osteolysis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 15, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THE MANUFACTURER RECEIVED A STRYKER COLLABORATIVE STUDY (SCS) NAMED "A POST-MARKET CLINICAL EVALUATION OF THE TREATMENT OF PELVIS FRACTURES WITH THE PELVIS NEXT GENERATION PLATES OF THE PRO IMPLANTS SYSTEM" THAT CONTAINS COLLECTED DATA ON THE USAGE AND THE OUTCOMES OF PRO PELVIS NEXT GENERATION IMPLANTS. RETROSPECTIVE ANALYSIS WAS CONDUCTED USING THE CLINIC DOCUMENTS AND RADIOGRAPHIC IMAGES OF CASES AT (B)(6) FROM JANUARY 2024- DECEMBER 2024 DURING THE REVIEW OF THE REPORT, IT WAS NOT POSSIBLE TO ESTABLISH A SPECIFIC DEVICE DETAIL, PATIENT INFORMATION, AND CURRENTLY NO ADDITIONAL DEVICE INFORMATION IS AVAILABLE; HOWEVER, THE FOLLOWING ADVERSE EVENT WAS REPORTED: PATIENT 9 DEVELOPED OSTEOLYSIS, ARTHRITIS, AND BONE FRACTURES ASSOCIATED WITH POST-TRAUMATIC OSTEOARTHRITIS AT 209 DAYS POST-OPERATIVELY. THIS EVENT WAS CATEGORIZED AS MODERATE AND IS STILL ONGOING WITHOUT NECESSITATING REVISION SURGERY. THE RELATIONSHIP TO BOTH THE DEVICE AND PROCEDURE WAS CONSIDERED POSSIBLY RELATED.

    Patient problems: Arthritis; Bone Fracture(s); Osteolysis

    MAUDE report 22026305 ↗

Other Plate, fixation, bone devices

All Plate, fixation, bone devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page